Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors

BACKGROUND: We have recommended active surveillance as the preferred management option for clinical stage I (CSI) testicular germ cell tumors (GCTs) since 1980. Over time, the recommended intensity of surveillance has decreased; however, the impact on relapse detection has not been investigated. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Gariscsak, Peter J., Anson-Cartwright, Lynn, Atenafu, Eshetu G., Jiang, Di Maria, Chung, Peter, Bedard, Philippe, Warde, Padraig, O'Malley, Martin, Sweet, Joan, Glicksman, Rachel M., Hamilton, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Testis Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142749/
https://www.ncbi.nlm.nih.gov/pubmed/35638085
http://dx.doi.org/10.1016/j.euros.2022.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142749/
https://www.ncbi.nlm.nih.gov/pubmed/35638085
http://dx.doi.org/10.1016/j.euros.2022.03.010

Ejemplares similares